Oak Ridge, TN, Aug. 28, 2023 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today issued a corporate update in a Letter to Shareholders filed in its six-month shareholder report on Form N-CSR on August 28, 2023 from CEO and President, Michael Feldschuh.…Read More
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
